Technologies Enabling Next Generation Vaccine Development

1.1 Research Scope: Vaccine Technologies Under Development Phase

1.2 Analysis Framework: Frost & Sullivan Core Value

1.3 Research Methodology: Five Steps Toward Success

1.4 Key Findings of Global Vaccine Technology Development

2.1 Research Scope: Current Status and Challenges of Vaccine Development

2.2 Technologies Transforming Next-generation Vaccines

3.1 Nanoparticles Enable Efficient and Safe Vaccine Delivery

3.2 Self-assembling Nanoparticles of Biological Origin

3.3 Polymeric and Inorganic Nanoparticles for Vaccine Delivery

4.1 Virus-like Particles Mimic The Real Viral Infection

4.2 Landscape of VLP-based Vaccines, Global, 2019

4.3 Influenza Shares A Major Portion of VLP-based Vaccines

4.4 Multiple Adaptations of VLP Technology for Vaccine Development

4.5 Plant Leaves Producing A Wide Variety of VLPs

5.1 Emerging Technologies for Bacterial and Fungal Vaccines

5.2 Emerging Bacterial and Fungal Vaccines, Global, 2019

5.3 New Strategies for Bacterial and Fungal Vaccines

5.4 Novel Vaccines & Therapeutics for Emerging Infectious Diseases

5.5 Multi-protein Complex-based Bacterial Vaccines

5.6 Carbohydrates-based or Conjugate Vaccines

6.1 Development Status of Synthetic Vaccines, Global, 2019

6.2 Peptides-based Vaccine Technologies

6.3 Genetically Modified Vaccines for HIV and Streptococci

7.1 Overview of Viral Vector-based Vaccines

7.2 Summary of Developing Viral Vector Vaccine Technology, Global, 2019

7.3 Diverse Replication-incompetent Viral Vaccines

7.4 Replication-incompetent Viruses with Nasal Spray Formulation

7.5 Live Attenuated Influenza Vaccines with Nasal Formulation

7.6 Viral Vector Vaccines for Serious Human Diseases

Flu vaccine based on regions of limited variability

8.1 Novel Lipid Formulations as Adjuvant

8.2 Oil-in-water Nanoemulsion and Saponin-based Adjuvants

8.3 Toll-like Receptor-based Adjuvants

9.1 Synopsis of Vaccine Synthesis, Formulation Delivery Platforms

9.2 Cell-free and Cell-based Vaccine Synthesis Platforms

9.3 Diverse Vaccine Formulation Technologies

9.4 Needle-less Solid Dose Vaccine Delivery Formulation and Device

9.5 Gold Nanoparticles and Applications in Vaccine Delivery

9.6 Nanopatch, Recombinant Protein and Lipid-based Carriers

10.1 Growth Opportunity 1: Influenza Vaccines

10.2 Growth Opportunity 2: Vaccines for Vector Borne Viral Diseases

10.3 Growth Opportunity 3: Vaccine Delivery Technologies

10.4 Strategic Imperatives for Success and Growth

11.1 Industry Interactions

Legal Disclaimer